Randomised Clinical Trial: Certolizumab Pegol for Fistulas in Crohn’s Disease - Subgroup Results From a Placebo-Controlled Study
Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/j.1365-2036.2010.04509.x
Full Text
Open PDFAbstract
Available in full text
Date
November 17, 2010
Authors
Publisher
Wiley